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Purpose: In order to monitor visual defects associated with macular degeneration
(MD), we present a new psychophysical assessment called multiline adaptive
perimetry (MAP) that measures visual field integrity by simultaneously estimating
regions associated with perceptual distortions (metamorphopsia) and visual
sensitivity loss (scotoma).
Methods: We first ran simulations of MAP with a computerized model of a human
observer to determine optimal test design characteristics. In experiment 1, predictions
of the model were assessed by simulating metamorphopsia with an eye-tracking
device with 20 healthy vision participants. In experiment 2, eight patients (16 eyes)
with macular disease completed two MAP assessments separated by about 12 weeks,
while a subset (10 eyes) also completed repeated Macular Integrity Assessment
(MAIA) microperimetry and Amsler grid exams.
Results: Results revealed strong repeatability of MAP and high accuracy, sensitivity,
and specificity (0.89, 0.81, and 0.90, respectively) in classifying patient eyes with severe
visual impairment. We also found a significant relationship in terms of the spatial
patterns of performance across visual field loci derived from MAP and MAIA
microperimetry. However, there was a lack of correspondence between MAP and
subjective Amsler grid reports in isolating perceptually distorted regions.
Conclusions: These results highlight the validity and efficacy of MAP in producing
quantitative maps of visual field disturbances, including simultaneous mapping of
metamorphopsia and sensitivity impairment.
Translational Relevance: Future work will be needed to assess applicability of this
examination for potential early detection of MD symptoms and/or portable
assessment on a home device or computer.
Introduction
Vision is the main modality with which we
navigate and interact with the environment. Conse-
quently, visual pathologies can induce limitations that
dramatically impair quality of life. The incidence of
visual diseases is increasing with the overall aging
population, leading to serious public health issues.1
Macular degeneration (MD) in particular represents
the leading cause of blindness in the Western World2
and it is projected to affect 3 million people by 2020 in
the United States alone.3 MD impairs primarily
central vision and has a detrimental impact on daily
tasks such as navigating, reading, and recognizing
faces, which can impose a severe cost to patients, their
families, and the health care system at-large.4
An early indicator of MD is the presence of
subretinal pockets of amorphous material called
drusen, which can cause morphological changes to
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the retinal array of photoreceptors and result in
measurable changes to perception such as regions that
appear blurry or distorted.5 This type of visual defect,
termed metamorphopsia, is a hallmark feature of MD
that in some cases may manifest even before disease
onset and can correlate tightly with locations of
anatomical features from retinal imaging.6 Later stage
progression of MD involves photoreceptor loss and
central scotomata that can cause complete loss of
high-acuity central vision.7 Currently, there are
limited treatment options for MD, particularly in
the earliest stages, and no standard intervention
exists. Better understanding of the etiology of MD
is important for prevention and treatment,8,9 but
other factors may be crucial for effective management
of the progressive disease including (1) a validated
procedure for earliest possible detection of disease
onset, as well as detecting clinically relevant changes
in disease status (e.g., choroidal neovascularization,
or CNV), and (2) a viable at-home method to
quantitatively track disease progression via self-
assessment between visits to the clinic to continuously
inform the course of treatment.
The primary protocol for at-home monitoring of
visual defects associated with MD is the Amsler grid.
In its standard form, the Amsler grid is a self-
administered paper-and-pencil assessment that con-
sists of a grid of equally spaced horizontal and vertical
lines, similar to a piece of graph paper,10 in which
users are instructed to fixate the center and subjec-
tively report all locations that appear perturbed or
distorted in any way. MD patients often report
regions where the straight lines appear blurry, wavy,
or missing altogether. While the Amsler grid is
ubiquitous due to affordability, portability, and
relative ease of use, there are well-documented
practical limitations associated with the Amsler grid
including poor sensitivity in detecting visual defects,
low compliance rates, and limited reproducibility due
to the subjective nature of reports.11 In fact, the
Amsler grid was not designed to produce quantitative
measurements of visual defects, nor to distinguish
subtle features characterizing the nature of those
deficits. Rather, the Amsler is best understood as a
coarse diagnostic tool for detecting central vision
impairment, but it does not provide reliable informa-
tion about the precise nature of the underlying
disturbance.
Since the degree of perceptual disturbance associ-
ated with MD naturally tends to mirror the progres-
sion of underlying disease status (i.e., retinal disarray
or photoreceptor loss), a fine-grained quantitative
assessment of visual field integrity could provide an
effective means for tracking MD symptomology to
allow earlier intervention, for example, by detecting
sudden onset of CNV to immediately refer patients to
the clinic, or by monitoring posttreatment remedia-
tion of visual function. Recent computerized assess-
ments, such as the Reichter Foresee preferential
hyperacuity perimetry (PHP),12 the Foresee HOME,13
the Radial Shape Discrimination test (RSD),14 and
the D-chart,15 aim to localize and quantify visual field
defects using patient responses to carefully controlled
visual stimuli and specialized scoring algorithms. For
example, PHP presents a horizontal or vertical dotted
line in which a subset of elements is slightly
misaligned in the shape of a small Gaussian ‘‘bump.’’
The patient is instructed to indicate the location of the
distorted region on each trial, and MD patients with
pathological distortion will often indicate erroneous
locations on the straight part of the line that appear
more distorted than the actual target bump. By
accumulating data across dozens of trials, the PHP
assessment can reference a normative database and
estimate the amplitude and likely location of patho-
logical distortions.16 A research study showed that
PHP had higher sensitivity in detecting CNV in
patients with age-related MD in comparison to the
Amsler grid,17 demonstrating the potential value of
using computerized assessments in clinical examina-
tion of MD.18 However, to date no computerized
assessment has been adopted in standard clinical
practice to augment the Amsler grid in daily/weekly
at-home assessment of vision.
In this paper, we present a new computerized
assessment called multiline adaptive perimetry (MAP)
that is designed to assess functional integrity of the
central visual field by providing quantitative mea-
surements of pathological distortions (e.g., metamor-
phopsia), as well as more severe defects associated
with visual sensitivity loss (e.g., scotoma). The MAP
task requires participants to identify bump-like
targets embedded in straight dotted lines that cross
the central visual field, similar in appearance to
stimuli used in the PHP assessment, but it includes
several methodological and analytical distinctions
including (1) the presentation of multiple simulta-
neous lines in each trial to facilitate various behav-
ioral responses, which we hypothesized would deliver
better time efficiency of the exam, (2) a procedure to
sample visual space adaptively on a trial-by-trial basis
to hone-in on regions suspected of retinal damage and
maximize information gained throughout the assess-
ment, and (3) statistical cluster analysis of three
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categories of responses (hits, misses, and false alarms
[FAs]) to simultaneously parse the visual field into
regions that are either functionally healthy, indicative
of metamorphopsia, or indicative of more generalized
loss of visual sensitivity (e.g., scotoma).
Methods
Participants
In experiment 1, we recruited 20 healthy partici-
pants (mean age 19.3 years, 10 males) from the UC
Riverside Department of Psychology Subject Pool.
Participants were given class credit for participation.
The protocol was approved by the UC Riverside
Institutional Review Board (IRB), and all partici-
pants gave written informed consent prior to the
study.
In experiment 2, we recruited eight clinical patients
diagnosed with various forms of macular disease at
the University of Alabama, Birmingham. Visual
characteristics, age, and diagnosis of the eight
participants are shown in Table 1. Participants were
offered transportation and were paid 10 dollars per
hour for voluntary participation. The study was
approved by the University of Alabama, Birmingham
IRB, and all participants gave written informed
consent prior to the study. Both studies adhered to
the principles set forth in the Declaration of Helsinki.
Method
Multiline Adaptive Perimetry (MAP)
MAP samples the visual field with horizontal or
vertical dotted lines, and adds ‘‘targets’’ to random
locations of the line by creating a subtle misalignment
to a subset of elements in the shape of a smooth
Gaussian ‘‘bump.’’ Participants are instructed to
locate these bumps and indicate them with a screen
touch or mouse click (Fig. 1). The framework for
analyzing and interpreting MAP performance is
conceptually related to signal detection theory in
which four possible outcomes exist: (1) Hit: a target
was present and reported correctly; (2) Miss: a target
was present but not selected; (3) FA: no target was
present but a straight location of the line was selected
as being distorted; and (4) Correct rejection: no target
was presented and no response was made.
Each one of these outcomes is potentially infor-
mative of specific aspects of the participant’s perfor-
mance and latent visual functioning. A hit is
considered as evidence for integrity of the retina and
normal visual function. A miss may represent a lapse
in performance (e.g., due to cognitive factors) or an
inability to detect the target as a result of retinal
damage or a loss in visual field sensitivity. When
misses tend to accumulate in particular regions of
visual space, this is strong evidence that the source of
performance impairment is likely retinal because
cognitive lapses should be unpredictable and distrib-
uted randomly. A FA is a distinctive event that
provides evidence for metamorphopsia because the
participant has reported seeing a distortion that was
not actually in the stimulus array. While individuals
with normal vision should make few FAs (if any) that
are randomly distributed in space, individuals with
metamorphopsia should tend to make many FAs that
are clustered in particular regions of space that
correspond to underlying retinal defects. Correct
rejections, by contrast, imply that the observer saw
the straight line as being straight and correctly
withheld response, thereby indicating an absence of
metamorphopsia. The theoretical and statistical
approach of MAP analysis is therefore to evaluate
the degree of spatial clustering of FAs to derive a
quantitative map of pathological visual field distor-
tions, and to evaluate the spatial distribution of hits
and misses to provide a measure of visual field
integrity (e.g., the accuracy of seeing and responding
to salient ‘‘bump’’ targets).
During the MAP assessment, a set of horizontal or
vertical dotted lines are drawn on the computer screen
spanning 678 across the central 148 of the visual field
(Fig. 1). Line locations are sampled from a set of 18
possible horizontal or 18 possible vertical locations
separated each by 0.758. When more than one line was
Table 1. Age, Clinical Diagnosis and Visual Acuity of
8 Patient Participants in Experiment 2
Subject
ID Diagnosis Age Vision
MD1 Wet AMD OU 73 20/73
MD2 Ocular histoplasmosis
syndrome OU
63 20/21
MD3 Central scotoma
unknown etiology OU
50 20/174
MD4 Diabetic retinopathy,
central scotoma OU
50 20/26
MD5 Stargardt’s OU 62 20/145
MD6 Myopic degeneration,
central scotoma OU
69 20/182
MD7 Dry AMD OU 62 20/25
MD8 Stargardt’s OU 22 20/166
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presented at a time, the assessment was programmed
to select lines that were at least 1.58 apart so there
would be no overlap between potential target bumps.
Square elements composing the dotted line had a
width of 0.28 and the blank distance between elements
was 0.18. A Gaussian bump (target) was randomly
placed along a line by adding a small displacement to
a subset of the points, which introduced a true
physical distortion to the stimulus array. Gaussian
bump targets were variable in size, with a width that
ranged from 1.08 to 1.58 and a height of line
displacement that ranged from 0.28 to 0.48. All target
sizes were chosen to be supra-threshold and easy to
detect for individuals with relatively normal vision.
The assessment could include a variable number of
target bumps on a given trial (e.g., typically one, two,
or three total targets), and the program was
constrained to allow only up to one randomly
positioned target on each line.
The stimulus array was displayed for 160 ms
(experiment 1) or 200 ms (experiment 2) in order to
minimize eye movements during display, and was
followed by a blank screen that included only the
fixation point as a continuous reference point.
Participants were instructed to use the touch screen
to quickly record locations in which a perturbation or
distortion was perceived to any of the briefly flashed
lines. A response was considered a hit if it was within
a threshold distance (18 for healthy participants in
experiment 1, 28 for patients in experiment 2) from the
centroid of an actual target location; otherwise, the
response was considered a FA. Participants pressed a
button to indicate when all distorted regions had been
manually selected to commence the following trial
with an intertrial interval of 2 to 4 seconds.
We developed an adaptive sampling algorithm in
which the probability of sampling a particular line
location was dependent on the frequency of prior FA
responses associated with that line. For example, as
the test progressed, if a particular line location was
presented and there was no FA on it (e.g., correct
rejection), then this was taken as marginal evidence
Figure 1. Schematic of the MAP to assess visual field integrity. (a) Upon fixation, horizontal or vertical dotted lines are flashed on the
screen for 160 ms (200 ms for MD participants). A variable number of target bumps are introduced in the lines, displacing a subset of
elements. Participants indicate where line distortions are perceived, and responses are classified as hits, misses, or FAs. For healthy
participants, we used a screen with white background and dark dotted lines, while for MD participants, the background was dark and the
dotted lines white. (b) Across many trials, FA responses are statistically evaluated for the degree of spatial clustering. Thresholded
statistical maps show regions of visual field with a degree of clustering significantly greater than chance. Patterns of accuracy across the
visual field are assessed by computing mean accuracy (hits/hitsþmisses) of behavioral responses within 2.58 radius of reference points,
for example, in a 7 by 7 grid.
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that there was no metamorphopsia anywhere along
that line, and the probability of sampling that region
in the future would decrease according to parameter
w1. On the other hand, if a line sample did result in a
FA then this was taken as evidence that there might
be metamorphopsia in a region crossed by that line,
and the probability of sampling that region in the
future increased according to parameter w2. In
simulations with a computer model (Supplementary
File S1), we evaluated a range of w1 and w2 values
and found a suitable balance between exploration/
exploitation using w1¼0.02 and w2¼ 0.1, in which
the relative influence of a FA was five times greater
than a correct rejection. MAP was initiated with a
uniform sampling distribution, where the probability
of sampling any line was equal to 1/18 (0.055).
Following each trial and the application of w1 and w2
to the sampling probability distribution, a new
distribution was created by re-normalizing the sum
across all possible line locations. The central idea
behind the adaptive algorithm was to increase the
future likelihood of sampling regions of the visual
field that had already accumulated prior evidence for
metamorphopsia and to hone-in on these regions
more quickly.
Macular Integrity Assessment (MAIA) Microperimetry
Exam
Microperimetry was performed (experiment 2)
using the MAIA, a microperimeter with inbuilt
confocal scanning laser ophthalmoscope and eye
tracker.19,20 MAIA uses a 25-Hz eye tracker to
monitor fixation, performs retinal imaging using a
scanning laser ophthalmoscope, and generates targets
by projecting light from a white light-emitting diode
(LED) directly onto the retina. MAIA measures
differential light sensitivity based on the ability of
observers to reliably report seeing a brief spot of light
at each sample location using a 4-2 threshold strategy
in which luminance is adjusted by increments of 4 dB
for increases and 2 dB for decreases. MAIA has a
dynamic range of 36 dB, where a value of zero
represents floor performance (poor sensitivity) and a
value of 36 represents ceiling (high sensitivity). MAIA
also measures fixation stability (FS) and uses an
automated eye-tracking system to account for eye
movements or poor fixation during stimulus presen-
tation. FS is represented by two indices, P1 and P2,
which represent the percentage of fixations within
circles of 18 and 28 radius, respectively. Eyes that have
a P1 value of at least 75% are classified as stable, eyes
that have a P2 value of at least 75% (but are not
classified as stable) are classified as relatively unsta-
ble, and eyes with P2 less than 75% are classified as
unstable.
Amsler Grid Exam
MD patients (experiment 2) performed a paper
Amsler grid exam (black lines on white background)
in the laboratory with the oversight of a trained
researcher (MKB). Subjective demarcations of per-
ceptual disturbances (blurry or wavy lines or holes) on
the grid (Supplementary Figure S1) were manually
digitized by an experimenter (SMT) to a digital image
with the same spatial resolution as the MAIA
microperimetry exam associated with that eye.
Specifically, each point in the digital image (e.g., a 7
by 7 image corresponding to retinal loci sampled by
MAIA) was labeled as either ‘‘healthy’’ or ‘‘patho-
logical’’ depending on whether the corresponding
region (within 618) was demarcated by the patient in
the paper version of the test.
Procedure
Evaluating MAP Design Characteristics
A key feature in designing MAP was the modifi-
cation and evaluation of different task characteristics
to develop the most objectively effective version of the
assessment. This included evaluating the impact of
using different numbers of simultaneous line stimuli,
different numbers of targets, and the maximum
number of responses allowed per trial, as well as
evaluating different methods of selecting line loca-
tions on each trial (e.g., whether locations were
chosen randomly or adaptively based on prior data).
We developed a realistic observer model in MATLAB
(MathWorks, Natick, MA) and ran thousands of
computer simulations of MAP with the model
observer (Supplementary File S1). Based on results
of the simulations, we found that the most efficacious
design for MAP included three-line stimuli per trial
and used an adaptive sampling routine for selecting
line locations on each trial of the assessment. These
characteristics demonstrated a significant improve-
ment for time-efficiency of the test so that equivalent
spatial accuracy in isolating regions of simulated
metamorphopsia could be achieved with fewer trials.
Experiment 1
Experiment 1 was designed to evaluate the ability
of MAP to isolate and detect simulated metamor-
phopsia in young healthy participants, and specifical-
ly, to evaluate a key prediction derived from the
observer model simulations (Supplementary File S1).
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The model predicted that employing three lines versus
only one line in the stimulus display would result in
substantially more FA responses, and would allow
MAP to converge faster (fewer trials) in measuring
statistically significant clustering to indicate distor-
tions of the visual field.
We programmed a system to simulate metamor-
phopsia in real-time (500 Hz) using an Eyelink 1000
tower eye-tracking device (SR Research, Mississauga,
Ontario, Canada). Participants were pseudo-random-
ly assigned to one of four groups, where each group
was assigned a ground truth region of metamorphop-
sia centered at one of four possible (x, y) locations
including (3,3), (þ3,þ3), (5,þ5), (þ5,5) degrees
relative to the fixation marker placed at (0, 0). These
locations were chosen strategically to span all four
quadrants of the visual field and to range in distance
from fovea. During stimulus display, eye gaze
location was continuously tracked binocularly and
the task was performed binocularly so as to maximize
eye tracking accuracy. The program waited until the
participant fixated on the central point for at least 200
ms prior to displaying the stimulus array, which was
shown for only 160 ms so there would be insufficient
time for a saccade away from fixation. Using the
continuously tracked gaze location, metamorphopsia
was simulated by creating a Gaussian distortion
(height ¼ 0.58, sigma ¼ 0.38) in real time to the
location of any line that happened to pass through the
assigned ground truth region. For example, if the
participant had a ground truth of (þ3, þ3) degree,
then if a sampled line happened to cross within 18 of
this location (þ3, þ3) relative to actual eye gaze
location, then a Gaussian bump would be added in
real-time to the stimulus array in that location. On
each refresh of the monitor (100 Hz), the program
updated the stimulus array to include such distortions
yoked to the position of eye gaze in near real-time.
These Gaussian distortions yoked to eye position
were similar in appearance to actual target bumps,
but for the purposes of analysis, responses to the
yoked targets were registered as FAs.
Participants performed the task under two condi-
tions presented in pseudorandom order across partic-
ipants. Condition 1 presented only one line per trial
with one randomly placed target every trial (analo-
gous to the PHP test). Condition 2 presented three
lines per trial with up to three randomly placed targets
(max of one target per each line), with a probability of
0.7 for one target present, 0.2 for two targets, and 0.1
for three targets. Participants were instructed to
‘‘press the screen in all locations where you perceive
a distortion to any line.’’ The trial was completed
either when participants pressed a button on the
screen to indicate that all perceived distortions had
been selected, or when the maximum number of
responses allowed was reached (up to four per trial).
Participants completed 64 total trials for each
condition, which took up to 10 minutes to complete.
A training procedure prior to the experiment helped
to familiarize participants to the task and ensured
they could respond with at least 90% accuracy to
target bumps.
Experiment 2
Experiment 2 was designed to evaluate repeatabil-
ity of MAP performance in patients diagnosed with
macular disease, and to statistically compare visual
field maps derived from MAP with those derived
from MAIA microperimetry and the Amsler grid.
Data were initially collected from three patients
(MD1–MD3) who performed the MAP assessment
twice (separated by 12 weeks) and who also had
records of a microperimetry exam performed within
the last 4 years. Amsler grid data were not available
for these three patients. We subsequently collected
data from five additional patients in which the
protocol was modified to acquire more proximal
MAIA microperimetry and Amsler grid exams
obtained during the same test and retest sessions as
MAP. In both cohorts, there was approximately a 12-
week period between visual assessments.
The MAP procedure was similar to experiment 1
but with a few modifications. We employed a single
MAP design that had three lines per trial, adaptive
sampling, and a total of 64 trials. Given the older age
of MD patients and general level of visual impair-
ment, the stimulus was presented for 200 ms (versus
160 ms used in experiment 1). Lastly, a trained
experimenter remained in the room with the partic-
ipant during testing. The participant was asked to
touch the location(s) on the screen where s/he saw a
distortion in the sampled lines, and then a researcher
would operate the mouse to click on those points.
Some of the patients had difficulty in navigating the
mouse cursor, and a touch screen monitor was not
available at the testing site, so this approach seemed a
reasonable compromise. During testing, the partici-
pant wore an eye patch over the eye that was not
being tested.
For three patients, the MAIA microperimetry
exam was conducted several months prior to the
recruitment of the participants. Specifically, for
patients MD1, MD2, and MD3 microperimetry was
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conducted 13, 33, and 44 months prior to the current
experiment, respectively. These examinations used
MAIA’s Goldmann-style 108/37-point meridional test
pattern centered on the fovea to assess full thresholds
at 37 retinal loci in a radial pattern. For patients MD4
to MD8, the MAIA exam was conducted on the same
days as MAP and used the 61-point linear test pattern
that included 49 loci within the central 148 of the
visual field corresponding to an equidistant 7 by 7
square grid spanning from6 to 68 in steps of 28. All
the tests were conducted monocularly in a quiet,
darkened room. Before testing, participants under-
went a brief period of training, allowing them to
familiarize themselves with the target stimulus and
practice correct operation of the response button. In
total, testing took approximately 40 minutes to 1
hour, including a short (3–5 minutes) break between
each successive test.
Analysis
Analyzing MAP Responses
Computing MAP Visual Field Accuracy Maps
We evaluated the distribution of hits and misses in
the MAP assessment to derive spatial maps of visual
field integrity based on task accuracy. We used the
MAIA sampling scheme associated with each partic-
ular eye (37-point radial scheme for MD1–MD3, or
49-point linear scheme for MD4–MD8) as a reference
for mapping MAP accuracy to a sparse grid that
could be directly compared to MAIA measurements
(Fig. 1b). For each retinal locus in the MAIA grid, we
found all the hits and misses within a 28 radius and
computed accuracy as hits/(hits þ misses). The MAP
accuracy value at each locus was only considered
valid if at least four targets (e.g., total of hits and
misses) had been presented within the 28 radius
circular region centered on that locus; otherwise this
value in the MAP was represented as NaN. Due to
random sampling, there were a few loci with
insufficient (e.g., less than four) target samples
(6.3% of all possible loci) and these loci were
disregarded in subsequent analyses.
Computing MAP Visual Field Distortion Maps
MAP FA responses were analyzed with a boot-
strapped clustering technique to identify retinal regions
suspected of metamorphopsia. Smoothed statistical
maps of visual field distortions were computed by
examining the probability associated with the spatial
clustering of FAs (Fig. 1b). The procedure for
computing the distortion map was as follows: (1)
create an image of zeros (160 by 160) spanningþ 88 of
the visual field from center, where each pixel represents
1/108, (2) replace a value of 1 for each of n FA
locations in the map, (3) smooth the image by
convolving with a 2d Gaussian filter (sigma ¼ 10 pix,
equivalent to 18), and (4) threshold the map according
to an appropriate statistical criterion. Any region that
exceeded the criterion, by definition, had clustering of
FAs that was unlikely to have occurred by chance and
therefore indicative of pathological retinal distortion.
To establish an appropriate criterion for evaluating
statistical significance, we used a random permutation
test to assess the distribution of maximum values
expected by chance (e.g., the method of maximums)
using an identical analysis pipeline on an equivalent
number of locations that were instead chosen uniformly
and randomly across visual space. For example, we
would simulate a thousand examples comprising n
random point locations and store the maximum value
from the resulting smoothed map to create a null
distribution of maximums. Intuitively, maximum values
of the simulated map tend to be high only when there is
clustering of points by chance; otherwise, the maximum
values will tend to be quite low. We used the 95th
percentile of this null distribution as the threshold for
evaluating statistical significance.
The thresholded FA distortion maps therefore
provide an estimate of the location and extent of
regions suspected of metamorphopsia. In experiment
2, in order to facilitate direct comparisons with
MAIA and Amsler grid outcome measures (analo-
gous to the computation of MAP accuracy maps at
particular loci) we resampled the distortion maps to
the same resolution as the MAIA reference grid. This
was performed in a fashion similar to the Amsler grid
data, where each point in the reference grid (e.g., the
loci sampled by MAIA) was labeled as either
‘‘healthy’’ or ‘‘pathological’’ depending on whether
the corresponding region (within 618) reached
statistical significance in the MAP FA distortion map.
Discriminating Eyes With Severe Pathology
A primary measure of the clinical utility of a visual
assessment designed for MD is its ability to distin-
guish eyes with minor pathology from eyes presenting
severe pathology. We used MAIA threshold mea-
surements as a relevant clinical standard for classify-
ing the severity of visual pathology. Severe pathology
was defined as having at least three MAIA threshold
measurements (out of either 37 or 49 loci) that were
each less than 5 dB, which would be associated with a
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regional loss of visual sensitivity and strongly
indicative of a scotoma or severe retinal damage.
We used receiver operator characteristic (ROC)
analysis to compute the sensitivity and specificity of
MAP accuracy values in discriminating eyes with and
without severe pathology.
We also evaluated the extent to which MAP FA
distortion maps could discriminate between healthy
versus pathological eyes defined, instead, by the
presence of a positive Amsler grid test (e.g., whether
or not the participant subjectively demarcated any
region at all on the Amsler grid). We report the
accuracy and sensitivity of the classification of Amsler
grid pathology using the binary variable specifying
whether or not there was any significant FA clustering
in the MAP distortion map.
Test–Retest Reliability of Visual Field
Patterns
We evaluated test–retest reliability of MAP, MAIA,
and Amsler grid visual field patterns using two
complementary techniques. We evaluated Pearson
product–moment correlation coefficients and intraclass
correlations (ICCs) to quantify the linear relationship
between the first and second tests. While the correlation
coefficients reveal the strength of positive relationship
between two measurements, they do not quantify the
absolute level of agreement. We therefore performed
parametric Bland-Altman analysis on test–retest mea-
sures for MAIA thresholds and for MAP accuracy
values to examine the bias (mean of test–retest
differences), upper and lower 95% limits of agreement
(ULA, LLA), and coefficient of reproducibility (COR)
defined as 1.96 times the standard deviation of test–
retest differences. The FA distortion maps and Amsler
grid assessments provide a binary outcome measure for
loci in the visual field (healthy ‘‘undistorted’’ versus
‘‘distorted’’), which is incompatible with the Bland-
Altman method. Direct comparison of measurements
between the different assessment types, which are
measured on inherently different spatial scales, was
achieved by resampling the Amsler grid and MAP
results to the same retinal loci sampled by MAIA
microperimetry. Test–retest reliability analysis was
therefore targeted at establishing the repeatability of
spatial visual field patterns across these specific loci.
Interassessment Consistency of Visual Field
Patterns
We evaluated the consistency of measurements
between pairs of different assessments (e.g., between
MAP and MAIA or between MAP and Amsler) using
Pearson correlation coefficients and ICC of measure-
ments across all retinal loci. We did not measure strict
agreement between the assessments because the
measurement units were on very different scales
(proportion correct for MAP, threshold decibels for
MAIA, binary labels for Amsler); however, we
expected the general consistency between assessments
to be suitably captured by evaluating the strength of
linear relationships between the outcome variables.
We evaluated the consistency between MAP accuracy
values and MAIA microperimetry thresholds, expect-
ing to find a positive linear relationship due to the fact
that low microperimetry thresholds are strongly
associated with anatomical defects (e.g., scotoma),
and observers should therefore have an impaired
ability to detect MAP targets presented to regions
affected by scotoma.
Similarly, we examined the consistency between
MAP FA distortion maps and Amsler grid maps in
terms linear correlation coefficients and ICC. We
evaluated consistency between the exams at two levels
including (1) the binary labels (healthy versus
pathological) from each exam associated with indi-
vidual visual field loci, and (2) the total regional area
demarcated on the Amsler grid and the area found to
be statistically significant in the MAP FA distortion
maps.
Results
Experiment 1
Experiment 1 was designed to compare perfor-
mance in the one-line versus three-line conditions with
respect to (1) how often participants made responses
to artificially distorted regions yoked to eye gaze
position (designated as FAs for purposes of analysis),
(2) how accurate the resulting maps were in localizing
the simulated metamorphopsia region, and (3) overall
how many individuals across the sample provided a
positive result in detecting the presence of metamor-
phopsia within the 64-trial limit. A positive test was
determined by whether there was a statistically
significant spatial clustering in the map. The estimate
of metamorphopsia location was determined by the
location of the peak in the statistical map, and spatial
accuracy was calculated as the Euclidean distance
between the centroid of the simulated distortion (the
‘‘ground truth’’) and the peak location. FA rate was
computed as the total number of FAs divided by the
number of trials.
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Thresholded statistical maps for each participant
are shown overlaid together with ground truth (blue
circle markers) for visual comparison in Figure 2.
Since our procedure simulated metamorphopsia in the
location centered on the blue markers, as expected, we
observed that a majority of significant FA clusters
(reddish pink regions) were found surrounding or
adjacent to the blue markers. As a group, 90% of the
participants in the three-line condition reached the
criterion for a statistically significant spatial clustering
within the 64-trial limit, whereas in the one-line
condition this was the case for only 45% of the
participants. This result has a strong similarity to
results of the simulated observer model (Supplemen-
tary File S1), which showed that it took only 50 trials
on average to reach criterion (defined as a positive
result with significant clustering) for the three-lines
condition, but took over 100 trials on average to
reach criterion in the one-line condition.
The higher likelihood of detecting simulated
metamorphopsia was driven by the fact that there
were significantly more FAs measured in the three-
line condition (mean ¼ 0.59 FAs/trial, SD ¼ 0.36) in
comparison to the one-line condition (mean ¼ 0.14
FAs/trial, SD ¼ 0.18) (t38 ¼ 4.98, P ¼ 0.013). There
was, however, no significant difference in spatial
accuracy for cases in which metamorphopsia was
successfully detected between the three-line (mean ¼
1.08, SD¼0.46) and one-line (mean¼0.80, SD¼0.52)
conditions (t25 ¼ .49, P ¼ 0.65). This result also
mirrors the outcome of observer model simulations
(Supplementary File S1), showing that localization
accuracy was comparable between the two conditions.
Thus, the ability of the three-line condition to better
detect metamorphopsia was driven principally by the
fact that it produced a higher rate of FAs.
These results show that the theoretical gains in
time-efficiency predicted by the ideal observer model
were largely confirmed in the results of experiment 1
with simulated metamorphopsia in young healthy
participants. The results also demonstrate, in princi-
ple, that the design and analysis technique employed
by MAP has the potential to measure real patholog-
Figure 2. Results for simulated metamorphopsia with healthy participants in experiment 1, with thresholded statistical maps of FA
clustering overlaid from each participant, and with ground truth shown for reference (blue circle markers), which represents the assigned
ground truth location for four different subject cohorts (a through d). The left panel in a to d represents maps from the one-line per trial
condition, and the right panel represents three-lines per trial condition. The reddish pink regions are statistically significant (P , 0.05) as
assessed with permutation testing, and have transparency so that darker red regions indicate more overlap across participants.
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ical distortions in MD patients through quantitative
maps of FA clustering.
Experiment 2
Experiment 2 was designed to assess the suitability
of MAP in measuring functional visual field abilities
in observers diagnosed with various types of macular
disease (Table 1) and with heterogeneous patterns of
retinal damage. Outcome measures for each patient,
eye, and test number are reported in Table 2 for
MAIA, MAP, and Amsler grid.
We performed ROC analysis to distinguish eyes
characterized as having severe visual pathology (Fig.
3a), defined as having at least three MAIA threshold
measurements less than 5 dB, which would be highly
indicative of a scotoma or regional loss of visual
sensitivity. ROC discriminability (n ¼ 26) was statisti-
cally significant (area under the curve¼ 0.89 60.06, P
, 0.0001), and results showed a sensitivity of 0.81 and
specificity of 0.90. The best cutoff value for meanMAP
accuracy was 0.61, indicating that a mean accuracy less
than 61% was highly diagnostic of the presence/
absence of severe visual pathology defined on the basis
of MAIA threshold sensitivity values.
We extended this analysis by assessing the relation-
ship between MAP accuracy measurements and MAIA
sensitivity thresholds categorized into three discrete
bins (Fig. 3c), across all retinal loci. A subset of loci
across all eyes (n¼ 127) showed relatively high function
and mean MAIA values greater than 27 dB, another
subset (n¼ 753) showed intermediate sensitivity greater
than 14 dB (but less than 27 dB), and another subset (n
¼ 532) showed low mean sensitivity less than 14 dB
(Fig. 3b). The mean MAP accuracy value for these
three MAIA levels was 0.54, 0.63, and 0.71, respective-
ly, which were all significantly different from each other
(t-tests, all Ps , 0.0001). This suggests a strong
statistical relationship between MAP accuracy and
MAIA thresholds, not just at the level of individual
eyes (as revealed by ROC analysis), but also at the finer
scale of individual retinal loci.
Next we examined the ability of MAP FA distortion
maps to distinguish eyes showing a positive Amsler grid
exam. Nineteen out of 20 eye exams showed a positive
Amsler grid and 18 out of 20 MAP assessments showed
significant spatial clustering of FAs to indicate
metamorphopsia. Overall the mean accuracy of classi-
fication of eyes as having positive Amsler grid
assessment was 0.85 with a sensitivity of 0.89. In
Table 2. Measurements Obtained by MAIA Microperimetry, MAP, and Amsler Grid for Each Participant, Each
Eye Examined, and Each of Two Tests Taken 12 Weeks Apart
Subject Eye
MAIA MAP Amsler
AT
(dB)
AT
(dB)
P1
(%)
P1
(%)
P2
(%)
P2
(%) A63 A63
Acc
(%)
Acc
(%)
FA
(area)
FA
(area) AREA AREA
Test 1 Test 2 Test 1 Test 2 Test 1 Test 2 Test 1 Test 2 Test 1 Test 2 Test 1 Test 2 Test 1 Test 2
MD1 OD 14.9 - 48 - 80 - 8.1 - 0.25 0.59 2.5 7 - -
OS 12.7 - 43 - 82 - 7.1 - 0.39 0.52 5.7 7 - -
MD2 OD 21.4 - 93 - 98 - 1 - 0.55 0.62 3.9 3.3 - -
OS 25.5 - 98 - 100 - 0.5 - 0.68 0.79 2.5 3.6 - -
MD3 OD 7.2 - 45 - 89 - 5.2 - 0.67 0.53 5.1 4.6 - -
OS - - 55 - 89 - 5 - 0.52 0.77 4.2 5.3 - -
MD4 OD 14.1 18.6 22 95 61 100 13 0.7 0.41 0.53 3.5 5.2 5.99 6.79
OS 25.9 25.9 91 91 96 96 1.4 1.4 0.71 0.67 4 3.5 4.93 8.04
MD5 OD 16.4 19.2 43 66 85 96 5.8 3.1 0.61 0.47 3.7 4.7 2.35 0
OS 14 11.9 53 69 91 96 4.6 3.2 0.41 0.51 2.8 5 0.77 1.82
MD6 OD 24.5 24.3 26 19 62 50 16.7 22.4 0.82 0.69 3.1 4.3 4.91 3.87
OS 23 24 24 27 51 64 26.5 16.4 0.77 0.76 3.4 4.8 3.83 4.25
MD7 OD 23.3 25.4 80 73 93 97 2.7 2.8 0.63 0.64 4.8 5.6 5.85 3.89
OS 26.9 27.4 76 72 97 93 2.7 3.6 0.81 0.87 0 0 1.63 2.04
MD8 OD 13.9 13.9 32 32 72 72 9 9 0.5 0.52 3.9 4.2 1.75 2.7
OS 15 12.9 51 46 92 88 4.6 5.7 0.64 0.49 3.8 4.1 1.81 4.22
AT, average threshold; Db, decibels; P2, measure of FS as percentage of fixations within 28 radius circle; A63, the area in
which 63% of fixations are found; Acc, mean accuracy (proportion correct) across retinal loci; FA, area of region passing 95%
statistical threshold in (deg^2); AREA, the area of all regions demarcated in Amsler grid exam (deg^2).
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general, this was a group of subjects selected on the
basis of having macular disease (19/20 Amsler exams
showed visual disturbance), and MAP FA distortion
maps were successful in confirming this diagnosis with
a positive test for majority of eyes tested (18/20).
Test–retest analysis (Table 3) showed that all four
types of visual field measurement had statistically
significant repeatability according to linear correla-
tion analyses. MAIA microperimetry showed the
strongest test–retest reliability (r(488) ¼ 0.65, P ,
0.0001), which is perhaps not surprising given that
this is a clinical-grade assessment that uses a scanning
laser ophthalmoscope and eye tracker in real time to
help ensure that stimuli are presented to precise
locations on the retina. The Amsler grid also
produced reliable binary measurements (r(488) ¼
0.30, P , 0.001) of whether individual loci were
classified as healthy or pathological. From MAP,
both the thresholded FA distortion maps and the
accuracy maps showed a similar level of reliability
(r(704) ¼ 0.38, P , 0.0001 and r(628) ¼ 0.42, P ,
0.0001, respectively). In terms of absolute agreement
of measurements across individual loci, the Bland-
Altman analysis revealed moderate agreement with a
rather high COR for both MAIA sensitivity mea-
surements (bias ¼ 2.08 dB, ULA ¼ 17.75 dB, LLA ¼
13.58 dB, COR ¼ 15.67) and for MAP accuracy
(bias¼ 0.04, ULA¼ 0.55, LLA¼0.47, COR¼ 0.51).
Figure 3. (a) ROC curve for classifying eyes labeled as pathological versus severely pathological (defined from MAIA microperimetry
thresholds) using mean MAP accuracy measurements. (b) Distribution of MAIA sensitivity values across all retinal loci from all eyes in the
study, where three discrete bins are defined to represent low, mid, and high level sensitivity. (c) Mean MAP accuracy and standard error
across loci categorized as low, mid, and high based on MAIA sensitivity level. *P , 0.0001.
Table 3. Pearson Correlation Coefficients and ICCs Representing Test–Retest Reliability and Interassessment
Consistency of Visual Field Measurements for MAIA Threshold Sensitivity, MAP Accuracy (MAP.Acc), MAP FA
Distortions (MAP.FA), and Subjective Amsler Grid Demarcations
df
Pearson ICC
r pval ICC lb ub f pval
Test–retest reliability
MAIA 488 0.65 0.00 0.63 0.57 0.68 4.35 0.00
MAP.Acc 628 0.42 0.00 0.40 0.34 0.47 2.35 0.00
MAP.FA 704 0.38 0.00 0.38 0.32 0.45 2.25 0.00
Amsler 488 0.36 0.00 0.36 0.28 0.43 2.14 0.00
Intertest consistency
MAIA-MAP.Acc 1072 0.35 0.00 0.34 0.28 0.39 2.01 0.00
Amsler-MAP.FA 988 0.01 0.66 0.02 0.09 0.04 0.96 0.72
Df, degrees of freedom; r, Pearson’s product moment correlation coefficient; pval, corresponding P value; lb, lower
bound of ICC; ub, upper bound of ICC; f, corresponding F-value associated with ICC.
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Next we examined the linear relationship between
MAIA sensitivity measurements and MAP accuracy
measurements across visual field loci to evaluate
whether these two distinct exams provided similar
measurements. MAIA measures light sensitivity and
MAP measures the ability to accurately detect the
location of target bumps, but both tasks depend on
proper visual sensitivity and functioning to achieve
high values. We found a strong and statistically
significant relationship between these two measures
(r(1072) ¼ 0.35, P , 0.0001), demonstrating that the
spatial patterning of MAIA sensitivity values was
broadly consistent with accuracy measurements ob-
tained by MAP. To account for the fact that eye label
(left, right) and exam number (test 1, test 2) were
likely correlated across measurements due to the fact
that these variables were nested within subjects, we
followed up the linear correlation analysis (which is a
conservative test that assumes independence of
measurements) by implementing a multilevel mixed-
effects linear model, with eye and exam number
nested within subjects as random effect variables, and
MAP accuracy values as a fixed effect variable to
explain MAIA sensitivity. Even after accounting for
eye and exam number nested within subjects, MAP
accuracy values remained a highly significant predic-
tor of MAIA values, t(1071.9) ¼ 5.03, P , 0.00001.
The full nested mixed-effects model had an adjusted r2
of 0.38, whereas a simple fixed-effects linear regres-
sion model had an adjusted r2 of 0.12.
By contrast, we did not find a statistically
significant relationship between Amsler grid results
and MAP FA distortion maps in terms of visual field
map patterns. This is interesting because while the
Amsler grid test and MAP FA maps each showed
strong repeatability from test to retest within them-
selves, there was no statistical relationship between
their measurements (r(988) ¼0.01, P ¼ 0.66) at the
level of individual retinal loci. We also examined
whether there was a linear relationship between the
two exams in terms of the total area of the visual field
demarcated as pathological (i.e., regions demarcated
subjectively via Amsler versus demarcated via statis-
tical FA clustering analysis for MAP; see Table 2).
We found no statistically significant relationship
between the estimated extent of pathology derived
from Amsler and MAP, r(18) ¼ 0.33, P ¼ 0.15.
Therefore, while each assessment is designed theoret-
ically to estimate similar underlying constructs (i.e.,
pathological distortions), the two exams appear to be
measuring distinct, but internally repeatable aspects
of visual function.
Selected Case Studies
Next we report details of specific case studies of
selected patients enrolled in the study. For patients
MD1 to MD4 and MD8, we report individual case
studies in Supplementary File S2. In the following
section, we selected three patients as representative
examples to discuss correspondence between anatom-
ical fundus images and outcomes measures from
MAP and MAIA microperimetry.
Patient MD5, Stargardt’s
Patient MD5 is a 62-year-old diagnosed with
bilateral Stargardt’s disease in which a substantial
deformation of the retina is visible in the fundus
image of OD and OS, with a scotoma encompassing
nearly the entire inferior region of the macula,
corresponding to the upper region of the visual field
(the central 148 is outlined with a white box in Fig. 4).
MAIA microperimetry confirms this observation
showing a near complete loss of visual sensitivity in
the inferior macula of both eyes, a result that was
highly repeatable from test 1 to test 2. MAP behavior
responses showed a consistent pattern with MAIA,
showing a tendency for more misses and FAs
occurring in the upper visual field (inferior macula
region). The MAP accuracy maps showed relatively
poor accuracy across the visual field, with a slight
tendency for lower accuracy in corresponding regions
of the inferior macula, but the boundary is not as well
defined as with MAIA. MAP metamorphopsia
distortion maps detected significant clustering in
lateral regions of the inferior macula, right along
the boundary and partially overlapping the scotoma
region. The thresholded distortion maps were quite
repeatable from test 1 to test 2, with OD showing a
distinct region centered 38 temporal and 38 inferior
relative to the fovea, with a radius of approximately
28. This result is very consistent with the region
demarcated on the test 1 of the Amsler grid; however,
on test 2 the patient failed to demarcate any region of
the Amsler grid. Due to consistent reporting of FAs in
this region throughout both examinations, there is
strong likelihood of visual disturbance (e.g., meta-
morphopsia) in this region on the boundary of the
scotoma. OS also showed a repeatable pattern of
metamorphopsia on the temporal and nasal bound-
aries of the anatomical scotoma in the inferior
macula. However, this result was inconsistent with
subjective demarcations on the OS Amsler grid for
tests 1 and 2, in which the patient indicated only very
small distortions at the nasal boundary (68–78) of the
inferior macula. In summary, MAP accuracy and FA
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distortion maps showed quite strong repeatability for
both eyes of MD5, and a strong correspondence with
retinal fundus images and patterns of MAIA sensi-
tivity thresholds. However, there was only low-to-
moderate consistency between FA distortion maps
and subjective Amsler grid reports.
Patient MD6, Myopic Degeneration
Patient MD6 is a 69-year-old diagnosed with
bilateral myopic degeneration in which the central
scotoma is not well-defined in the fundus images (Fig.
5). MAIA microperimetry showed a relatively good
level of visual sensitivity across the entire visual field,
with no single locus showing a complete loss in visual
sensitivity (e.g., all MAIA thresholds. 15 dB) and an
average threshold of 24 6 2.4 dB across both eyes on
tests 1 and 2. MAP behavior responses showed a
similar pattern in which there were few misses that did
not tend to cluster in visual space, and MAP accuracy
was relatively high across the entire visual field, with
an average accuracy of 0.76 6 0.18 across both eyes
on tests 1 and 2. Both MAP and MAIA indicate
moderate impairment of visual sensitivity and rela-
tively intact visual field integrity. The thresholded
distortion maps did show distinct patterns of patho-
logical distortion that were very repeatable from test 1
to test 2 of each eye. In particular, for eye OS there
was significant clustering of FAs between 28 and 48
nasal and 08 to 38 of the superior macula (corre-
sponding to lower-right of visual field), and a radius
of about 18 to 28. There was another area of
significant clustering in the middle temporal macula
revealed in test 2. The Amsler grid showed a similar
pattern on test 1 and test 2 that was quite consistent
with FA distortion maps, with multiple distributed
foci marked as subjective distortions. For eye OD,
there was less consistency in the location of thresh-
olded regions from test 1 to test 2, but across both
exams there was a tendency for FAs to occur in a
circular pattern forming a ring of metamorphopsia
with radius of 38 to 68 centered at the fovea. This
spatial pattern with multiple distributed foci was also
demonstrated quite strikingly in the Amsler grid
reports for tests 1 and 2, but was found to be shifted
slightly inferior relative to the FA distortion maps. In
summary, MAP accuracy and MAIA sensitivity
thresholds showed a similar pattern of intact visual
function across the entire visual field, yet MAP FA
Figure 4. (Upper panel) Fundus image of OD and OS for patient
MD5 diagnosed with Stargardt’s disease with box identifying the
central 148 of the visual field centered on the fovea. (Lower panels)
Test measurements from test 1 and test 2 associated with MAP and
MAIA, overlaid on the corresponding location of the retina
centered on the fovea. MAP data were scaled, inverted, and then
mirror reversed to transform from Cartesian coordinates to
approximate retinal fundus image coordinates. The first lower
panel shows MAP behavioral responses including FAs (red dots),
hits (green dots), and misses (blue dots); the second lower panel
shows MAP accuracy values resampled to the same resolution as
the reference MAIA grid for direct comparison of measurements
across retinal loci between the two tests. The third lower panel
shows MAIA threshold sensitivity values. The fourth lower panel
shows thresholded FA distortion maps, where regions marked red
indicate a statistically significant degree of clustering for FA
 
responses. The fifth lower panel shows a mirror-reversed projection
of subjective Amsler grid demarcations onto the fundus image for
easier visual comparison the FA distortion maps.
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distortion maps revealed repeatable patterns to
indicate metamorphopsia in parafoveal regions that
were roughly consistent with the distributed pattern
of multiple Amsler grid demarcations of subjective
distortion.
Patient MD7, Dry Age-Related MD (AMD)
Patient MD7 is a 62-year-old diagnosed with dry
AMD and good visual acuity (20/25). MAIA
thresholds for eye OD showed a substantial loss of
sensitivity in the superior-temporal part of the macula
(the lower right of the visual field), suggesting a visual
defect (i.e., scotoma) in this specific region (Fig. 6). By
contrast, MAIA thresholds for eye OS were high
across the entire visual field on tests 1 and 2. MAP
accuracy maps also showed a general reduction of
accuracy in the superior macula for OD and
correspondingly broad levels of high accuracy for
OS on tests 1 and 2. This outcome highlights the tight
relationship between MAIA microperimetry thresh-
olds and MAP accuracy measurements at both the
Figure 6. (Upper panel) Fundus image of OD and OS for patient
MD7 diagnosed with dry AMD. The lower panels are the same as
described in Figure 4.
Figure 5. (Upper panel) Fundus image of OD and OS for patient
MD6 diagnosed with myopic degeneration and central scotoma.
The lower panels are the same as described in Figure 4.
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level of mean performance for individual eyes, and at
a finer scale including spatial patterns across retinal
loci. Interestingly, for OD the FA distortion maps
showed a highly repeatable pattern of significant FA
clustering in and around the boundary of the scotoma
region. Likewise, the Amsler grid showed large
demarcations of subjective distortion in the superior
macula in and around the location of scotoma. The
degree of clustering of FA responses in this region,
together with the reduction of MAP accuracy,
strongly suggests severe pathology in this area of the
macula. By contrast, eye OS generated very few FAs
during the MAP exam and had high visual sensitivity,
indicating an integral OS visual field. While the FA
distortion maps revealed no significant degree of
clustering for OS, the Amsler grid did show a few very
small areas demarcated as subjectively distorted.
Discussion
MD is a progressive disease affecting central vision
and represents the primary cause of blindness in
western countries. Early diagnosis and constant
monitoring may be crucial for both prompt interven-
tion and actionable assessment of progressive disease
states. Indeed, recent studies have shown that timely
interventions can be critically important in these
patients,21 with new drugs available that can prevent
further vision loss21–24 and improve vision in approx-
imately one-third of MD patients. The Amsler grid is
commonly used as a simple and practical way to
screen for MD and to track MD symptoms via self-
administration at home. However, the Amsler grid
has limitations that make it unsuited for quantita-
tively measuring and tracking changes in visual
functioning. In this paper, we propose a psychophys-
ical test called MAP that is designed to localize and
quantify central visual field deficits (e.g., metamor-
phopsia and scotoma) that are associated with various
types of retinal disease including MD.25–27
We assessed the theoretical ability of MAP to
quantitatively map simulated visual field disturbances
by evaluating its accuracy and efficiency using
simulations with a computer model observer. In
experiment 1, we empirically tested predictions from
this model, and confirmed that the most efficacious
design for MAP included three-line stimuli per trial
and adaptive line sampling. With respect to proce-
dures that use only one line stimulus per trial (e.g., the
PHP test), MAP with three lines significantly
increased testing efficiency by increasing the rate of
FAs, and reduced the number of trials needed to
isolate regions suspected of metamorphopsia. A
principal feature and benefit of assessing MAP with
the observer model and the healthy vision population
in experiment 1 was to be able to control and specify a
priori the location and extent (the ground truth) of
the distorted region. For example, there is inherent
difficulty in determining the true retinal regions
associated with metamorphopsia in patients due to
the subjective, perceptual nature of the disturbance,
as well as idiosyncratic manifestations of the disease
in each individual as well as changes over time.
It is important to note that despite surface
similarity in stimulus appearance (e.g., dotted lines
with target bump displacements) between PHP16 and
MAP, there are several significant distinguishing
factors. The PHP allows exactly one response per
trial with the understanding that true stimulus
distortions will compete with perceptual distortions
in other locations, and the observer will likely choose
the most severe distortion (hence the ‘‘preferential’’
aspect of the test). By comparison, on any given trial,
an observer in MAP responds to all perceived
distortions, including true targets and pathological
distortions. The analytical basis of MAP is instead to
examine the spatial patterning and statistical cluster-
ing of behavioral responses (hits, misses, and FAs) as
a means of estimating spatial maps of visual field
integrity and visual field distortion. Intuitively, MAP
would benefit from employing more line stimuli in
order to maximize the number of opportunities for
these types of behavioral responses to occur, thereby
increasing the amount of information gained on every
trial. A quick procedure would be of significant utility
since the patient might be able to quickly check their
vision on a daily basis.
In experiment 2, we tested MAP in eight MD
patients (16 different eyes). Results showed good test–
retest reliability, as well as consistency between MAP
measurements and MAIA sensitivity thresholds. In
fact, mean MAP accuracy measurements were able to
distinguish severe visual pathology, determined inde-
pendently from MAIA microperimetry values, with
high accuracy, sensitivity and specificity equal to 0.89,
0.81, and 0.90, respectively. MAIA is a high precision
technology that would obviously not be replaced by a
psychophysical examination like MAP; however, the
ability of MAP to approximate retinal patterns of
MAIA sensitivity measurements suggests that MAP
could serve as a useful surrogate method for obtaining
frequent at-home measurements of visual field integ-
rity between visits to the clinic. While promising, these
preliminary data should be interpreted with caution,
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as more research in nonclinical groups will be
necessary to build normative data sets and to
demonstrate the ability of MAP on a larger scale to
discriminate the degree of visual pathology with both
high sensitivity and specificity for low-vision patients
and healthy vision individuals.
A promising feature of MAP is the potential ability
to provide quantitative estimates of the location and
extent of retinal areas affected by metamorphopsia.
For several MD patients, our work illustrates strong
test–retest reliability of visual field distortion maps
estimated from clustering of FA responses accumu-
lated during the MAP assessment. Further, the
anatomical estimates of metamorphopsia in these
participants were generally found within or along the
borders of the scotoma, which is consistent with the
literature on metamorphopsia.26,28 Late-stage MD
patients with central visual field loss often rely more
upon their peripheral vision and develop a preferred
retinal locus (PRL), an eccentric fixation point used in
substitution of the fovea.29 However, even for late
stage MD, for which the treatment consists of
improving vision in the periphery, and learning to
use a sensitive or favorably located peripheral fixation
spot (trained retinal locus [TRL]30), metamorphopsia
mapping may have beneficial use. TRL localization is
often based on anatomical examination of the fundus
of the eye and/or sensitivity maps,31 which may fail to
reveal metamorphopsias that could hinder the chosen
TRL.
Interestingly, although the FA distortion maps
were internally reliable in terms of test–retest, there
was a lack of strong evidence for spatial consistency
between MAP estimates of metamorphopsia and
those obtained subjectively from Amsler grid exam-
inations. The idea behind the Amsler grid is to track
retinal defects via patterning of manual demarcations
of subjectively perceived visual distortions. However,
we found insignificant relationship to patterns of
distortions indicated during the MAP exam. This
discrepancy may be due to methodological differences
including the fact that the Amsler grid is shown
continuously on the entire visual field and allows
patients to move their eyes around as they draw/circle
the areas of visual distortion, whereas MAP isolates
visual pathologies from statistical clustering of FAs to
line stimuli presented so briefly as to prohibit eye
movements away from fixation. Since it is difficult to
establish a ground truth for distorted vision and
subtle retinal deformations in MD patients, it remains
unclear whether MAP provides relatively better
diagnostic or clinically useful information about
metamorphopsia.
Finally, a possible additional element that might
have contributed to the observed discrepancy is the
specific version of the Amsler grid used in this study,
the modified Amsler grid, where a black grid is
presented over a white background (differently from
the original Amsler grid, where a white grid is
presented over a black background). While the
modified version has practical advantages (i.e., it
makes it easier to mark with a pencil the regions of
distortion), it has also been shown to be less sensitive
with respect to its original version.10 Additional data
should be collected in future studies with patient
monitoring longitudinally across several weeks or
months in order to address this question more fully.
Taken together, these results demonstrate that
MAP presents a number of potential advantages and
features with respect to current techniques. Presenting
multiple lines per trial with adaptive sampling reduced
the effective duration of the assessment, and our
analysis of response clustering allowed simultaneous
parsing of the visual field into three functionally
relevant categories. The spatial resolution of MAP
could allow combining MAP with microperimetry to
project measurements of visual field functional
integrity onto the anatomical surface of the retina to
get a more composite view of visual abilities beyond
light sensitivity.
The current limitations of MAP are the result of
common difficulties in dealing with clinical popula-
tions in general, and with MD patients in particular.
A typical characteristic of MD, the loss of central
vision, might lead to poor fixation stability in the
PRL, thus limiting the spatial accuracy of the visual
field mapping. To help overcome this issue in
principal, we integrated a gaze contingent display in
experiment 1 with healthy observers to allow presen-
tation of the stimuli in specific locations relative to
fixation. In future work, gaze contingency of stimulus
display could also be incorporated with patients to
have better control of retinal stimulation during MAP
assessment. Another known difficulty is due to the
older age of AMD patients in general, which could
induce low compliance and a lower tolerance to
fatigue. We therefore plan to evaluate different
adaptive procedures tailored to various patient
populations to hone-in on regions suspected of
scotoma and/or metamorphopsia as quickly and
efficiently as possible. Future directions would also
involve adapting MAP into accessible programs that
can be run on a laptop or tablet computer, allowing
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for a greater number of participants and the
possibility of testing rehabilitation protocols for
patients performing the assessment at home. More-
over, the MAP test could benefit in the future from
clinicians’ and ophthalmologists’ feedback on imple-
mentation with various heterogeneous groups of
patients.
In summary, MAP shows the potential to be an
effective and quick tool for measuring functional
visual abilities and capturing the presence and
location of visual field disturbances. Indeed, a timely
diagnosis can be crucial in MD intervention, since
new treatments for MD are available that can
preserve residual vision in these patients.32 Further
research is needed to examine whether MAP may be
useful as a diagnostic tool for detecting early MD and
whether MAP measurements may be useful for
tracking disease progression over time to detect the
onset of CNV, or wet AMD, which can cause sudden
and pervasive damage to the retina. Though more
research will be needed in a larger clinical sample, as
well as with healthy individuals and those at risk for
MD, the present results demonstrate the potential of
MAP as a diagnostic and rehabilitative tool to
monitor the status of visual retinal functions, which
we expect may help reduce costs and increase
accessibility by comparison to other exams that
require more expensive and dedicated equipment.
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